Skip to main content

Table 3 Distribution of patients who had and did not have TEE, in accordance with CHA2DS2-VASc and HAS-BLED risk scores

From: Findings of transoesophageal echocardiogram in appropriately anticoagulated patients with persistent atrial fibrillation prior to planned cardioversion

 

CHA2DS2-VASc score

 

0

1

2

3

4

5

6

7

8

TEE was performed (n, %)

0

0%

9

7.5%

26

21.7%

23

19.2%

32

26.7%

19

15.8%

8

6.7%

3

2.5%

0

0%

TEE was not performed

(n, %)

5

1.6%

21

6.7%

65

20.8%

58

18.6%

74

23.7%

55

17.6%

27

8.7%

6

1.9%

1

0.3%

 

HAS-BLED score

 

0

1

2

3

4

 

TEE was performed (n, %)

42

35.0%

42

35.0%

26

21.7%

7

5.8%

3

2.5%

TEE was not performed

(n, %)

95

30.4%

140

44.9%

64

20.5%

12

3.8%

1

0.3%

  1. TEE transoesophageal echocardiography